Position in BCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$103,088,880
+$78,421,154 QoQ
Shares Held
10,308,888
+226.0% QoQ
Ownership
4.03%
of shares outstanding
% of Portfolio
1.66%
of 13F equity value
Holder Rank
#8
of 316 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PERCEPTIVE ADVISORS LLC holds $274,177,982 across 5 Drug Manufacturers - Specialty & Generic names. BCRX ranks #2 (37.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
8,334,882 | $149,694,480 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
10,308,888 | $103,088,880 | |
| 3 | EOLS |
Evolus, Inc.
|
2,459,285 | $17,067,437 | |
| 4 | XERS |
Xeris Biopharma Holdings, Inc.
|
467,013 | $3,698,742 | |
| 5 | CPIX |
Cumberland Pharmaceuticals Inc
|
96,982 | $628,443 |
All Filings in BCRX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $103,088,880 | 10,308,888 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $24,667,726 | 3,162,529 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||